Massachusetts H5223 authorizes a study on health insurance, including prescription drugs, copay assistance, and pharmacy networks.
Massachusetts H5223 directs the Financial Services committee to investigate and study various health insurance-related petitions. These include issues around prescription drugs, copay assistance for certain branded drugs, and the promotion of preferred pharmacy networks. The study also covers the establishment of a public health insurance option and the use of maximum allowable costs lists by payers and pharmaceutical benefit managers. The committee will report findings and recommendations to the General Court.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.